Ken Griffin Ars Pharmaceuticals, Inc. Comm Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Citadel Advisors LLC holds 1,586,033 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,586,033
Previous 2,242,176
29.26%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions